ID | 116090 |
Author | |
Keywords | Hyperuricemia
Urate-Lowering Therapy
Selective Urate Reabsorption Inhibitor
Chronic Kidney Disease
Preventing Early Renal Loss in Diabetes
American College of Rheumatology
|
Content Type |
Journal Article
|
Description | Hyperuricemia is a clinical important problem and its prevalence has been increased. Latest topics are described. The guideline adequately managing gout was published from American College of Rheumatology (ACR). Various optimal uses of urate-lowering therapy (ULT) were presented. The cardiorenal effects of hyperuricemia have been investigated for years. Regarding the patients on chronic kidney disease (CKD) and high risk of progression, ULT with allopurinol did not show the decline in eGFR compared to the control. Recently, dotinurad that is a new selective urate reabsorption inhibitor (SURI) would be applied to medical practice. Low-dose dotinurad showed satisfactory pharmacological efficacy.
|
Journal Title |
Diabetes Research : Open Access
|
Publisher | Asploro
|
Volume | 3
|
Issue | 1
|
Start Page | 16
|
End Page | 19
|
Published Date | 2021-04-27
|
Rights | This is an open-access article distributed under the Creative Commons Attribution License(https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
|
DOI (Published Version) | |
URL ( Publisher's Version ) | |
FullText File | |
language |
eng
|
TextVersion |
Publisher
|
departments |
Medical Sciences
|